Comparative study of skin phototoxicity with three drugs by an in vivo mouse model

Journal of Toxicological Sciences

Volumn 35, Issue 1, 2010, Pages 97-100

  Matsumoto, Norihito ^a   Akimoto, Akira ^a   Kawashima, Hiroyuki ^a   Kim, Soonih ^a  

^a ONO PHARMACEUTICAL CO   (Japan)

Author keywords

Mouse; Photosafety; Phototoxicity

Indexed keywords

LOMEFLOXACIN; QUINOLINE DERIVATIVE; SPARFLOXACIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; MOUSE; NONHUMAN; PHOTOTOXICITY; SKIN TOXICITY; TOXICITY TESTING;

MUS;

EID: 76749135824     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.35.97     Document Type: Article

References (8)

1. Bertex Pharmaceuticals, Inc. (2003): Drug label of Zagam (sparfloxacin).
2. Mayne, J.T., Johnson, N.J., Kluwe, W.M., Lencoski, D.L. and Polzer, RJ. (1997): A study of the phototoxic potential of trovafloxacin in BALB/c mice. J. Antimicrob. Chemother., 39, 67-73.
3. OECD (2004): OECD Guidelines for the testing of chemicals, No. 432: In vitro 3T3 NRU phototoxicity test. Paris, France: Organization for economic cooperation and development.
4. Owen, K. (1998): Comparative grepafloxacin phototoxicity in mouse skin. J. Antimicrob. Chemother., 42, 261-264.
5. Shimoda, K., Ikeda, T., Okawara, S. and Kato, M. (2000): Possible relationship between phototoxicity and photodegradation of sita-floxacin, a quinolone antibacterial agent, in the auricular skin of albino mice. Toxicol. Sci., 56, 290-296.
6. Unimed Pharmaceuticals, Inc. (2001): Drug label of Maxaquin (lomefloxacin hydrochloride).
7. Wagai, N., Yamaguchi, F., Sekiguchi, M. and Tawara, K. (1990): Phototoxic potential of quinolone antibacterial agents in Balb/c mice. Toxicol. Lett, 54, 299-308.
8. Wagai, N., Yamaguchi, F., Tawara, K. and Onodera T. (1989): Studies on experimental conditions for detecting phototoxic potentials of drugs in Balb/c mice. J. Toxicol. Sci., 14, 197-204.